Ellen Sidransky

20.2k total citations · 3 hit papers
235 papers, 12.5k citations indexed

About

Ellen Sidransky is a scholar working on Physiology, Cell Biology and Molecular Biology. According to data from OpenAlex, Ellen Sidransky has authored 235 papers receiving a total of 12.5k indexed citations (citations by other indexed papers that have themselves been cited), including 209 papers in Physiology, 143 papers in Cell Biology and 72 papers in Molecular Biology. Recurrent topics in Ellen Sidransky's work include Lysosomal Storage Disorders Research (207 papers), Cellular transport and secretion (141 papers) and Carbohydrate Chemistry and Synthesis (68 papers). Ellen Sidransky is often cited by papers focused on Lysosomal Storage Disorders Research (207 papers), Cellular transport and secretion (141 papers) and Carbohydrate Chemistry and Synthesis (68 papers). Ellen Sidransky collaborates with scholars based in United States, Israel and Canada. Ellen Sidransky's co-authors include Nahid Tayebi, Grisel Lopez, Barbara Stubblefield, Mary E. LaMarca, Edward I. Ginns, Wendy Westbroek, Özlem Göker-Alpan, Kathleen S. Hruska, Ehud Goldin and Arash Velayati and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Ellen Sidransky

231 papers receiving 12.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies

2011 1.0k citations Ellen Sidransky et al. profile →
Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson’s disease

2014 382 citations Nahid Tayebi, Ellen Sidransky et al. profile →
Lysosomal dysfunction in neurodegeneration: emerging concepts and methods

2022 117 citations Yu Chen, Ellen Sidransky et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Ellen Sidransky	9.0k	6.0k	4.0k	3.4k	2.5k	235	12.5k
Dimitri Krainc	4.5k 0.5×	2.4k 0.4×	5.0k 1.2×	8.3k 2.4×	377 0.2×	135	15.5k
Kinuko Suzuki	3.4k 0.4×	1.5k 0.2×	720 0.2×	3.8k 1.1×	591 0.2×	170	9.3k
Marie T. Vanier	6.8k 0.8×	1.7k 0.3×	324 0.1×	2.7k 0.8×	2.1k 0.8×	141	9.3k
Michael G. Schlossmacher	5.0k 0.6×	1.4k 0.2×	6.9k 1.7×	3.7k 1.1×	268 0.1×	81	11.6k
Andrew B. West	2.6k 0.3×	1.5k 0.3×	6.9k 1.7×	5.0k 1.5×	276 0.1×	129	11.9k
Shoji Tsuji	3.3k 0.4×	1.5k 0.2×	6.7k 1.7×	8.8k 2.6×	382 0.2×	507	17.1k
Leonidas Stefanis	3.6k 0.4×	2.1k 0.3×	7.4k 1.8×	4.8k 1.4×	110 0.0×	277	13.4k
Steven U. Walkley	4.3k 0.5×	1.8k 0.3×	261 0.1×	2.0k 0.6×	969 0.4×	109	6.3k
Han Seok Ko	2.0k 0.2×	1.0k 0.2×	4.2k 1.0×	4.0k 1.2×	138 0.1×	58	8.5k
Philipp J. Kahle	3.0k 0.3×	1.2k 0.2×	6.9k 1.7×	5.0k 1.5×	124 0.1×	124	11.9k

Countries citing papers authored by Ellen Sidransky

Since Specialization

Citations

This map shows the geographic impact of Ellen Sidransky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Sidransky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Sidransky more than expected).

Fields of papers citing papers by Ellen Sidransky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Sidransky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Sidransky. The network helps show where Ellen Sidransky may publish in the future.

Co-authorship network of co-authors of Ellen Sidransky

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Sidransky. A scholar is included among the top collaborators of Ellen Sidransky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Sidransky. Ellen Sidransky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Glasstetter, Logan M., Abhijeet Kapoor, Sha Zhu, et al.. (2024). High-throughput screening for small-molecule stabilizers of misfolded glucocerebrosidase in Gaucher disease and Parkinson’s disease. Proceedings of the National Academy of Sciences. 121(42). e2406009121–e2406009121. 8 indexed citations

Wincovitch, Stephen, et al.. (2024). A Comparative Biochemical and Pathological Evaluation of Brain Samples from Knock-In Murine Models of Gaucher Disease. International Journal of Molecular Sciences. 25(3). 1827–1827. 5 indexed citations

Toffoli, Marco, Elisa Menozzi, Stephen Mullin, et al.. (2024). Consensus Guidance for Genetic Counseling in GBA1 Variants: A Focus on Parkinson's Disease. Movement Disorders. 39(12). 2144–2154. 3 indexed citations

Sidransky, Ellen, et al.. (2024). Characterization of Novel Human β-glucocerebrosidase Antibodies for Parkinson’s Disease Research. Journal of Parkinson s Disease. 14(1). 65–78. 4 indexed citations

Chen, Tiffany, et al.. (2024). Advancements in Viral Gene Therapy for Gaucher Disease. Genes. 15(3). 364–364. 12 indexed citations

Chen, Yu, et al.. (2024). Gaucher disease provides a unique window into Parkinson disease pathogenesis. Nature Reviews Neurology. 20(9). 526–540. 15 indexed citations

Lopez, Grisel, Jens Lichtenberg, Dietrich Haubenberger, et al.. (2023). Rapid-Onset Dystonia and Parkinsonism in a Patient With Gaucher Disease. Journal of Movement Disorders. 16(3). 321–324. 3 indexed citations

Blauwendraat, Cornelis, Nahid Tayebi, Grisel Lopez, et al.. (2023). Polygenic Parkinson's Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher Disease. Movement Disorders. 38(5). 899–903. 11 indexed citations

McKinney, Cindy E., et al.. (2021). The Role of Exosomes in Lysosomal Storage Disorders. Biomolecules. 11(4). 576–576. 17 indexed citations

10.

Sidransky, Ellen, David Arkadir, Peter Bauer, et al.. (2019). Substrate Reduction Therapy for GBA1‐Associated Parkinsonism: Are We Betting on the Wrong Mouse?. Movement Disorders. 35(2). 228–230. 12 indexed citations

11.

Ryan, Emory, et al.. (2019). Mutations, modifiers and epigenetics in Gaucher disease: Blurred boundaries between simple and complex disorders. Molecular Genetics and Metabolism. 128(1-2). 10–13. 10 indexed citations

12.

Aflaki, Elma, Daniel K. Borger, Nima Moaven, et al.. (2016). IPSC-derived dopaminergic neurons from patients with Gaucher disease and Parkinsonism demonstrate the potential of a new glucocerebrosidase chaperone. Molecular Genetics and Metabolism. 117(2). S15–S15. 1 indexed citations

13.

Goldstein, David S., Courtney Holmes, Patti Sullivan, et al.. (2015). Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration. Parkinsonism & Related Disorders. 21(9). 1013–1022. 27 indexed citations

14.

Velayati, Arash, Melanie A. Knight, Barbara Stubblefield, Ellen Sidransky, & Nahid Tayebi. (2011). Identification of Recombinant Alleles Using Quantitative Real-Time PCR. Journal of Molecular Diagnostics. 13(4). 401–405. 10 indexed citations

15.

Velayati, Arash, Nidhi Gupta, Jae Hyuk Choi, et al.. (2011). A mutation in SCARB2 is a modifier in gaucher disease. Human Mutation. 32(11). 1232–1238. 68 indexed citations

16.

Motabar, Omid, Ellen Sidransky, Ehud Goldin, & Wei Zheng. (2010). Fabry Disease – Current Treatment and New Drug Development. PubMed. 4. 50–56. 39 indexed citations

17.

Sidransky, Ellen, Gregory M. Pastores, & Motomi Mori. (2009). Dosing enzyme replacement therapy for Gaucher disease: older, but are we wiser?. Genetics in Medicine. 11(2). 90–91. 11 indexed citations

18.

Ziegler, Shira G., Kathleen S. Hruska, Barbara Stubblefield, et al.. (2009). In silico and functional studies of the regulation of the glucocerebrosidase gene. Molecular Genetics and Metabolism. 99(3). 275–282. 11 indexed citations

19.

Göker-Alpan, Özlem, Benoit I. Giasson, Michael J. Eblan, et al.. (2006). Glucocerebrosidase mutations are an important risk factor for Lewy body disorders. Neurology. 67(5). 908–910. 168 indexed citations

20.

Uchida, Yoshikazu, Mariko Hara, Hiroyuki Nishio, et al.. (2000). Epidermal sphingomyelins are precursors for selected stratum corneum ceramides. Journal of Lipid Research. 41(12). 2071–2082. 187 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact